Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells

Nucleosides, Nucleotides and Nucleic Acids

Volumn 23, Issue 8-9, 2004, Pages 1541-1544

  Bauer, W ^a   Horvath, Z ^a   Hochtl T ^a   Saiko, P ^a   Karl, D ^a   Fritzer Szekeres, M ^a   Szekeres, T ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Amidox; Ara C; Combination chemotherapy; Ribonucleotide reductase

Indexed keywords

AMIDOX; ANTINEOPLASTIC AGENT; BENZOIC ACID DERIVATIVE; CYTARABINE; DEOXYADENOSINE TRIPHOSPHATE; DEOXYCYTIDINE TRIPHOSPHATE; DEOXYGUANOSINE TRIPHOSPHATE; ENZYME INHIBITOR; RIBONUCLEOTIDE REDUCTASE; RIBONUCLEOTIDE REDUCTASE INHIBITOR; THYMIDINE TRIPHOSPHATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CELL STRAIN HL 60; CONFERENCE PAPER; CYTOTOXICITY; DNA SYNTHESIS; DRUG TARGETING; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROMYELOCYTIC LEUKEMIA;

AGAR; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTARABINE; DEOXYCYTOSINE NUCLEOTIDES; DRUG SYNERGISM; ENZYME INHIBITORS; HL-60 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; OXIMES; RIBONUCLEOTIDE REDUCTASES; TIME FACTORS;

ARA;

EID: 10344238081     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-200027766     Document Type: Conference Paper

References (7)

1. Elford, H.L.; Freese, M.; Passamani, E.; Morris, H.P. Ribonucleotide reductase and cell proliferation. J. Biol. Chem. 1970, 245, 5228-5233.
2. Takeda, E.; Weber, G. Role of ribonucleotide reductase in the expression of the neoplastic program. Life Sci. 1981, 28, 1007-1014.
3. Elford, H.L.; Wampler, G.L.; van't Riet, B. New ribonucleotide reductase inhibitors with antineoplastic activity. Cancer Res. 1979, 39, 844-851.
4. Fritzer-Szekeres, M.; Salamon, A.; Grusch, M.; Horvath, Z.; Höchtl, T.; Steinbrugger, R.; Jäger, W.; Krupitza, G.; Elford, H.L.; Szekeres, T. Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells. Biochem. Pharmacol. 2002, 64, 481-485.
5. Howell, B.H.; Gill, S.; Elford, H.L. Modulation of cytarabine metabolism in the human promyelocytic leukemia cell line HL-60 by polyhydroxy-substituted benzohydroxamic acids. Cancer Treat. Rep. 1982, 66, 1825-1829.
6. Bhalla, K.; Swerdlow, P.; Grant, S. Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabinofuranosylcytosine in highly resistant human leukemia cells. Blood 1991, 78, 2937-2944.
7. Grusch, M.; Fritzer-Szekeres, M.; Fuhrmann, G.; Rosenberger, G.; Luxbacher, C.; Elford, H.L.; Smid, K.; Peters, G.J.; Szekeres, T.; Krupitza, G. Activation of caspases and induction of apoptosis by novel ribonucleotide reductase inhibitors amidox and didox. Exp. Hematol. 2001, 29, 623-632.